Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian G Wicha

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2026
Meropenem and fosfomycin against K. pneumoniae: towards a combination breakpoint using a pharmacometric approachAneeq Farooq, Miklas Martens, Marie L G Attwood, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 29, 2020
Stability studies with tigecycline in bacterial growth medium and impact of stabilizing agentsLisa F Amann, Emilia Ruda Vicente, Mareike Rathke, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 31, 2026
'Meropenem and fosfomycin against K. pneumoniae' - Author's replyAneeq Farooq, Miklas Martens, Marie L G Attwood, et al.
International Journal of Antimicrobial Agents|January 30, 2015
TDMx: a novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routineSebastian G Wicha, Martin G Kees, Alexander Solms, et al.
Therapeutic Drug Monitoring|March 31, 2022
Dosing for Personalized Prophylaxis in Hemophilia A Highly Varies on the Underlying Population Pharmacokinetic ModelsDavid W Uster, Pratima Chowdary, Anne Riddell, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2024
Pharmacokinetic/pharmacodynamic analysis of meropenem and fosfomycin combinations in in vitro time-kill and hollow-fibre infection models against multidrug-resistant and carbapenemase-producing Klebsiella pneumoniaeAneeq Farooq, Miklas Martens, Niklas Kroemer, et al.
Clinical Pharmacology and Therapeutics|February 22, 2020
Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical DevelopmentBudi O Susanto, Sebastian G Wicha, Yanmin Hu, et al.
Pharmaceutical Research|April 12, 2022
A Machine Learning Approach to Predict Interdose Vancomycin ExposureMehdi Bououda, David W Uster, Egor Sidorov, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 25, 2023
Contact-Biocide TiO<sub>2</sub> Surfaces by Surface-Initiated Atom Transfer Radical Polymerization with Chemically Stable Phosphonate InitiatorsEilika Zorn, J Iven H Knaack, Nils Burmeister, et al.
Blood Advances|January 8, 2024
Chimeric antigen receptor T-cell therapy and fludarabine: precision dosing imperativesSebastian G Wicha, Eva M A Wansing, Adrin Dadkhah, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2026
Meropenem and fosfomycin against K. pneumoniae: towards a combination breakpoint using a pharmacometric approachAneeq Farooq, Miklas Martens, Marie L G Attwood, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 29, 2020
Stability studies with tigecycline in bacterial growth medium and impact of stabilizing agentsLisa F Amann, Emilia Ruda Vicente, Mareike Rathke, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 31, 2026
'Meropenem and fosfomycin against K. pneumoniae' - Author's replyAneeq Farooq, Miklas Martens, Marie L G Attwood, et al.
International Journal of Antimicrobial Agents|January 30, 2015
TDMx: a novel web-based open-access support tool for optimising antimicrobial dosing regimens in clinical routineSebastian G Wicha, Martin G Kees, Alexander Solms, et al.
Therapeutic Drug Monitoring|March 31, 2022
Dosing for Personalized Prophylaxis in Hemophilia A Highly Varies on the Underlying Population Pharmacokinetic ModelsDavid W Uster, Pratima Chowdary, Anne Riddell, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2024
Pharmacokinetic/pharmacodynamic analysis of meropenem and fosfomycin combinations in in vitro time-kill and hollow-fibre infection models against multidrug-resistant and carbapenemase-producing Klebsiella pneumoniaeAneeq Farooq, Miklas Martens, Niklas Kroemer, et al.
Clinical Pharmacology and Therapeutics|February 22, 2020
Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical DevelopmentBudi O Susanto, Sebastian G Wicha, Yanmin Hu, et al.
Pharmaceutical Research|April 12, 2022
A Machine Learning Approach to Predict Interdose Vancomycin ExposureMehdi Bououda, David W Uster, Egor Sidorov, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 25, 2023
Contact-Biocide TiO<sub>2</sub> Surfaces by Surface-Initiated Atom Transfer Radical Polymerization with Chemically Stable Phosphonate InitiatorsEilika Zorn, J Iven H Knaack, Nils Burmeister, et al.
Blood Advances|January 8, 2024
Chimeric antigen receptor T-cell therapy and fludarabine: precision dosing imperativesSebastian G Wicha, Eva M A Wansing, Adrin Dadkhah, et al.
Pageof 12